Text · Comparison of two versions
Changes from report parliamentary committee draft to plenary report
ENVI-PR-763253 → A-10-2025-0020
- From
- ENVI-PR-763253 report parliamentary committee draft of 23 Oct 2024
- To
- A-10-2025-0020 Plenary report of 25 Feb 2025
- Changes
- 6 changes to the text
- Paragraphs
- +27 added · −4 removed · 4 changed
More facts (3)
- Dossier
- 2023/0455(COD)
- Title (from)
- on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EC) No 178/2002, (EC) No 401/2009, (EU) 2017/745 and (EU) No 2019/1021 as regards the re-attribution of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals
- Title (to)
- on the proposal for a regulation of the European Parliament and of the Council amending Regulations (EC) No 178/2002, (EC) No 401/2009, (EU) 2017/745 and (EU) No 2019/1021 of the European Parliament and of the Council as regards the re-attribution of scientific and technical tasks and improving cooperation among Union agencies in the area of chemicals
AI: What changed, in short Written by AI from the official text — check the source · deepseek-v4-flash · 4 Sept 2026
Strengthens procedures for resolving scientific divergences between agencies, prioritizing protective opinions for vulnerable groups and requiring joint reports if unresolved.124 Adds provisions for extending deadlines when additional information is requested and for monitoring ECHA resources and governance.15 Extends changes to other regulations: endocrine disruptors in medical devices and POPs waste reporting and consultation.5 The other changes are formal: a heading for the final vote is added.6
The notes class 5 changes as substance, 1 as formal, 0 as wording only.
Changes that matter, 6
Changes to the text in document order — the ones the change notes describe. Cover page, renumbering and punctuation-only edits are left out (see “Every difference”); changes to citations and references stay in and are marked as formal in the notes.
Change 1
AddedRecital 8: (8) Correspondingly, this Regulation aims to address the eventual divergence between scientific opinions of the European Food Safety Authority and those of other Union agencies. Regulation (EC) No 178/2002 of the European Parliament and Council already contains provisions establishing a procedure to solve divergent scientific opinions. Those resolution procedures should be reinforced, in that the European Food Safety Authority and the other dissenting agency should be bound to make their best effort to resolve the divergence on general scientific issues. Differences in assessment methodologies resulting in divergent opinions, particularly with regard to the protection of vulnerable groups, should be duly justified. In such instances, priority should be given to the most protective opinion to safeguard vulnerable groups. Only when they are not able to resolve the divergence, should they refer to risk managers.
AddedRecital 9: (9) In the more specific case of scientific divergence pertaining to the hazard identification of chemical substances, a new procedure enabling the resolution of the divergence should be established. This procedure should enable the Commission to request the European Chemicals Agency, as the Union agency most equipped with expertise and capacity in hazard assessment, as well as long-standing experience with the harmonised classification and labelling process, to develop a proposal for harmonised classification and labelling, in accordance with Regulation (EC) No 1272/2008 of the European Parliament and Council, moving closer to the ‘one substance, one assessment’ vision as regards uniformity of hazard assessments of chemicals across the Union, enhancing the protection of health and the environment. This possibility should be reflected in the relevant provision providing for the resolution of diverging scientific opinions laid down in Regulation (EC) No 178/2002.
AddedRecital 14 a (new): (14a) This Regulation expands the tasks, workload and remit of the scientific committees of the European Chemicals Agency. In order to provide adequate expertise, support and thorough scientific evaluations, appropriate and stable resources, capacity and governance of the scientific committees should be ensured. In this respect, the European Commission should regularly monitor the needs of the European Chemicals Agency stemming from this Regulation, and provide the Agency with sufficient and stable resources.
AI: Note on change 1 · substance Written by AI from the official text — check the source · deepseek-v4-flash · 4 Sept 2026
Adds three recitals: reinforcing procedures to resolve divergent scientific opinions, establishing a new procedure for hazard identification divergences, and ensuring adequate resources for ECHA's scientific committees.
Change 2
ChangedArticle 1 – paragraph 1 – point 2, Article 30: 4. Where a substantive divergence30 over– scientificparagraph issues2 has– beensubparagraph identified1: andWhere the body in questionAuthority isidentifies a Memberpotential Statesource body,of thedivergence, Authorityit andshall thecontact nationalthe body shallconcerned bein obligedorder to cooperateensure withthat aall viewrelevant toscientific eitheror resolvingtechnical theinformation divergenceis orshared preparingand ain jointorder documentto clarifyingidentify the potentially contentious scientific issuesor andtechnical identifyingissues. theDifferences relevantin uncertaintiesassessment inmethodologies theresulting data.in Thisdivergent documentopinions shall be madeduly public.justified, especially regarding the protection of vulnerable groups.
AI: Note on change 2 · substance Written by AI from the official text — check the source · deepseek-v4-flash · 4 Sept 2026
Replaces Article 30(4) with a new paragraph requiring the Authority to contact the body concerned, share information, and justify differences in assessment methodologies, prioritizing protection of vulnerable groups.
Change 3
RemovedA clear incentive for all the bodies involved in the process to work towards resolving divergent views is still missing. Paragraph 4 (deleted in the new version by the Commission) is restored, in order to ensure that all the bodies involved in the process work together with a view to either resolving the divergence or preparing a joint document clarifying the contentious scientific issues. Plant protection products formulations are almost always manufactured for the common European market, not for individual Member states. This means divergence in opinions on co-formulants across Member states leads to fragmentation of the common market, single sourcing and supply chain risk.
AI: Note on change 3 · substance Written by AI from the official text — check the source · deepseek-v4-flash · 4 Sept 2026
Adds justification for restoring deleted paragraph 4, emphasizing the need for cooperation to avoid market fragmentation due to divergent opinions on co-formulants.
Change 4
ChangedArticle 1 – paragraph 1 – point 2, Article 30 – paragraph 4 a (new): 4a. In cases2 where– asubparagraph divergence2: isThe identified,Authority and the Authoritybody requestsconcerned additionalshall informationcooperate fromto resolve the otherdivergence, Unionwith agenciesthe oraim bodies,of orensuring Memberthe Statehighest bodies,level theof periodprotection byof whenhealth and the relevantenvironment. authoritiesPriority areshall requiredbe togiven adoptto theirthe respectiveopinion output,that oraffords the jointhighest reportlevel referredof toprotection in paragraphorder 2to ofsafeguard thisthe Article,most shouldvulnerable begroups. sufficient.If Afterthe consultingAuthority and the body concerned,concerned are not able to resolve the Authoritydivergence, they shall laydraw downup a period withinjoint whichreport. thisThe informationreport shall beclearly providedoutline andthe shallcontentious informscientific issues, identify the Commissionrelevant ofuncertainties thein additionalthe perioddata needed.and Thethe Commissionpossible shallcauses informfor the concerneddiverging businessopinions, operator(s)including andon themethodological Memberdifferences, Statesand ofbe themade extension.publicly available.
AI: Note on change 4 · substance Written by AI from the official text — check the source · deepseek-v4-flash · 4 Sept 2026
Replaces Article 30(4a) with new subparagraphs requiring cooperation to resolve divergence, prioritizing most protective opinion, and drawing up a joint report if unresolved.
Change 5
RemovedWhen it comes to procedures for authorisation of regulated products, specific legal deadlines apply. The difficulty resulted from this is how accommodate the necessary time for cooperation to resolve divergences within the specific deadlines given in the sectorial legislation. No time frame or allocation of extra time is prescribed for resolving divergences under Article 30(2). The proposed mechanism allows sufficient time to resolve this issues, and is inspired from Article 6 of Regulation 1331/2008.
AddedRegulation (EC) No 178/2002
AddedArticle 1 – paragraph 1 – point 2, Article 30 – paragraph 3 a (new): 3a. Where a substantive divergence over scientific issues has been identified and the body in question is a Member State body, the Authority and the national body shall be obliged to cooperate with a view to either resolving the divergence or preparing a joint document clarifying the contentious scientific issues and identifying the relevant uncertainties in the data. That document shall be made public.
AddedRegulation (EC) No 178/2002
AddedArticle 1 – paragraph 1 – point 2, Article 3 – paragraph 3 b (new): 3b. In cases where a divergence is identified, and the Authority requests additional information from the other Union or Member State authority, the period within which the relevant authorities are required to adopt their respective output, or the joint output referred to in paragraph 2, may be extended. After consulting the body concerned, the Authority shall lay down a period within which that information is to be provided and shall inform the Commission of the additional period needed. The Commission shall inform the business operators and the Member States concerned of the extension.
AddedRegulation (EU) 2017/745
Show 18 more lines
AddedArticle 3 – paragraph 1 – point 1, Annex I – Section 10.4.1 – point b: (b) substances which are classified as endocrine disruptors for human health, of Category 1, in accordance with Part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council12 and substances having endocrine-disrupting properties for which there is scientific evidence of probable serious effects to human health and which are identified in accordance with the procedure set out in Article 59 of Regulation (EC) No 1907/2006 of the European Parliament and of the Council or substances having endocrine disrupting properties relevant to human health identified in accordance with Regulation (EU) No 528/2012. / 12 Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).
AddedRegulation (EU) 2019/1021
AddedArticle 4 – paragraph 1 – point 2, Article 8 – paragraph 1a – subparagraph 1 – point a: (a) information on human health and environmental impacts of waste consisting of, containing or contaminated with POPs, including impacts on waste management;
AddedRegulation (EU) 2019/1021
AddedArticle 4 – paragraph 1 – point 2, Article 8 – paragraph 1a – subparagraph 2: The Agency shall, as soon as it receives the request referred to in Article 8(1), point (i), publish on its website a notice that a report on a possible amendment of Annex IV or V will be prepared inviting all interested parties, including waste operators and users of recycled materials, to submit comments within 8 weeks. The Agency shall publish those comments on its website.
AddedRegulation (EU) 2019/1021
AddedArticle 4 – paragraph 1 – point 2, Article 8 – paragraph 1a – subparagraph 3: At the latest 9 months following the submission of the report referred to in Article 8(1), point (i), the Committee for Socio-economic Analysis of the Agency, set up pursuant to Article 76(1), point (d), of Regulation (EC) No 1907/2006 shall adopt an opinion on the report and on the concentration limit values proposed therein. For the purpose of adopting an opinion on the report, Article 87 of Regulation (EC) No 1907/2006 shall apply mutatis mutandis.
AddedRegulation (EU) 2019/1021
AddedArticle 4 – paragraph 1 – point 4, Article 15 – paragraph 2: 2. The Commission is empowered to adopt delegated acts in accordance with Article 18, to amend Annexes IV and V to adapt them to the changes to the list of substances set out in Annexes I, II or III to Regulation (EU) 2019/1021, or the Annexes to the Convention or the Protocol or to adapt them to scientific and technical progress.
AddedRegulation (EU) 2019/1021
AddedArticle 4 – paragraph 1 – point 4 a (new), Article 16 – paragraph 2 a (new): (4a) In Article 16, the following paragraph is added: / "2a. The Commission shall monitor the situation regarding the resources of the European Chemicals Agency and tasks, workload and remit of the scientific committees of the European Chemicals Agency and present, where necessary, a legislative proposal to reflect any needs of the European Chemicals Agency stemming from tasks introduced by this Regulation and to improve the governance of its scientific committees."
AddedRegulation (EU) 2019/1021
AddedArticle 4 – paragraph 1 – point 5 – point c, Article 18 – paragraph 6: 6. A delegated act adopted pursuant to Articles 4(3), 10(2) and 15 shall enter into force only if no objection has been expressed either by the European Parliament or by the Council within a period of two months of notification of that act to the European Parliament and the Council or if, before the expiry of that period, the European Parliament and the Council have both informed the Commission that they will not object. That period may be extended by two months at the initiative of the European Parliament or of the Council’.
AddedRegulation (EU) 2019/1021
AddedRegulation (EU) 2019/1021
AddedRegulation (EU) 2019/1021
AddedRegulation (EU) 2019/1021
AddedRegulation (EU) 2019/1021
AI: Note on change 5 · substance Written by AI from the official text — check the source · deepseek-v4-flash · 4 Sept 2026
Adds multiple amendments: new paragraphs on cooperation and extension of deadlines, changes to medical devices regulation on endocrine disruptors, and several amendments to POPs regulation on reporting and monitoring.
Change 6 under “EXPLANATORY STATEMENT”
AddedINAL VOTE BY ROLL CALL BY THE COMMITTEE RESPONSIBLE
AI: Note on change 6 · formal Written by AI from the official text — check the source · deepseek-v4-flash · 4 Sept 2026
Adds a heading for the final vote by roll call by the committee responsible.
Sources & citation
Where the facts on this page come from, and how to cite it.
- Data source
- Licensed CC BY 4.0.
- Retrieved
- 25 September 2026
Cite as
European Parliament (2025). “Changes between ENVI-PR-763253 and A-10-2025-0020”. Text, 25 February 2025. from ENVI-PR-763253, to A-10-2025-0020, reference 2023/0455(COD). EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/texts/ENVI-PR-763253/compare/A-10-2025-0020 (retrieved 25 September 2026). Data: European Parliament Open Data, https://data.europarl.europa.eu/ (CC BY 4.0).
BibTeX
@misc{epw-text-2025-02-25,
author = {{European Parliament}},
title = {{Changes between ENVI-PR-763253 and A-10-2025-0020}},
year = {2025},
date = {2025-02-25},
howpublished = {\url{https://news.eu-parl.st-solutions.dev/texts/ENVI-PR-763253/compare/A-10-2025-0020}},
url = {https://news.eu-parl.st-solutions.dev/texts/ENVI-PR-763253/compare/A-10-2025-0020},
urldate = {2026-09-25},
publisher = {EU Parl Watch Research},
note = {Text. from ENVI-PR-763253, to A-10-2025-0020, reference 2023/0455(COD). Data: European Parliament Open Data (CC BY 4.0)}
}